Linked from

The 22 pages that link to Drug-induced liver injury, each with the reason it gives.

• Adverse drug reactionBroader topic: It is a potentially severe organ-specific form of adverse drug reaction.

• Liver biopsyRelated: Tissue patterns can help distinguish drug injury from competing causes of abnormal liver tests.

• Liver function testsRelated: Liver-test patterns and their timing help identify a possible medication-related cause.

• HepatocyteRelated: Hepatocytes metabolize many drugs and can be injured by parent compounds or reactive products.

• CholestasisRelated: Some drugs impair bile transport or formation and trigger cholestasis.

• HepatotoxicityBroader topic: This is the clinical form of hepatotoxicity attributed to therapeutic agents.

• Acute liver failureNarrower topic: Drug toxicity is a major cause of acute liver failure, especially acetaminophen overdose.

• Drug allergyRelated: Some immune-mediated drug reactions involve the liver as a target organ.

• Stevens–Johnson syndromeRelated: Medication review must account for serious reactions beyond the skin.

• TerbinafineNarrower topic: This broader safety problem includes the rare liver injury associated with terbinafine.

• DiclofenacRelated: Diclofenac can rarely cause clinically significant liver injury, so prolonged use may require monitoring.

• Autoimmune hepatitisCompared with: Some drugs produce hepatitis-like findings and can complicate diagnosis.

• HepatitisRelated: Some cases produce hepatitis-like inflammation after a drug exposure.

• Primary biliary cholangitisCompared with: Some drugs cause a cholestatic pattern that can resemble this disease but follows an exposure.

• Dubin–Johnson syndromeCompared with: Unlike the inherited syndrome, medication-related abnormalities may reflect active liver damage and require a different response.

• Hepatitis ECompared with: It can resemble viral hepatitis clinically, so exposure history and HEV testing may prevent misattribution.

• MethyldopaRelated: Rare hepatic reactions have been reported with methyldopa and may require stopping treatment.

• Non-alcoholic fatty liver diseaseCompared with: Medication-related injury is one alternative cause clinicians consider when evaluating fatty liver.

• Toxic epidermal necrolysisCompared with: Both conditions can be serious drug reactions, but they injure different organs.

• IbogaineRelated: Liver injury has been reported after ibogaine use, adding to its medical risks.

• ThiamazoleNarrower topic: Thiamazole’s rare hepatic adverse effects are one instance of this broader complication.

• Toxic injuryBroader topic: It illustrates how toxic injury can target a particular organ.